Senior Pharma Pricing & Policy Investment Strategist

Capstone LLC; Washington (District of Columbia); Hybrid; USD 90,000 - 120,000; Full time

Benefits offered by this job

Health insurance

Vision insurance

Dental insurance

Paid vacation

Travel stipend

401(k)

Job summary

Capstone LLC in Washington, DC is seeking a Senior Associate for Healthcare Policy & Investment (Pharma). The role demands 4+ years of experience in pharma pricing or healthcare policy, with strong skills in Excel, SQL, and Python to analyze pricing structures, rebates, and market access.

You will work with government or commercial claims data and translate insights into investment opportunities, reports, and strategic recommendations.

Qualifications

• 4+ years of relevant experience in pharma pricing, market access, policy analysis, or healthcare consulting.
• Deep knowledge of rebate structures and reimbursement models.
• Strong quantitative and technical skills: Excel, SQL, and Python proficiency required.
• Experience with government or personal claims data.

Responsibilities

• Analyze pharma pricing structures, reimbursement models, and rebate mechanics to identify investment opportunities.
• Work with large datasets and apply quantitative skills (Excel, SQL, Python) to develop insights.
• Monitor policy developments affecting pharma pricing, market access, and rebates.
• Synthesize findings into clear, data-driven reports and recommendations.
• Collaborate with policymakers, investors, and healthcare stakeholders.

Skills

Excel

SQL

Python

Data analysis

Pharma pricing

Education

Bachelor's degree

Job description

Capstone LLC in Washington, DC is seeking a Senior Associate for Healthcare Policy & Investment (Pharma). The role demands 4+ years of experience in pharma pricing or healthcare policy, with strong skills in Excel, SQL, and Python to analyze pricing structures, rebates, and market access.

You will work with government or commercial claims data and translate insights into investment opportunities, reports, and strategic recommendations.